Presented
by

Presented by Oxford Global

Member Login
|
Become a Member

Next Up

3D Cell Culture: Online

13 September 2022 |

BST (UTC+1)

13 September 2022

BST (UTC+1)

Our 3D Cell Culture congress incorporates key trends and innovative technologies to accelerate the adoption of 3D models in preclinical research via advanced development, validation and application strategies.

> Visit Event Website

07 Nov 2022
Mon, 07 November 2022

Cell UK: In-Person

> Visit Event Website

Mar 2023
March 2023

Cell Therapy Analytics Symposium

More Information Coming Soon

Apr 2023
April 2023

3D Cell Culture UK: In-Person

More Information Coming Soon

> See All Upcoming Oxford Global Cell Events
> See All Webinars & Recordings

Highlights

When to Cut and When to Inhibit
Commentary
When to Cut and When to Inhibit? A Low-Throughput, Hands-On Investigation Of CRISPR-Cut and CRISPRi Efficiencies In iPSC And Neural Cells
Gene knockdown – the manual reduction of a particular gene's expression in target cells – entails the modification of cellular development in young cells. CRISPR gene editing techniques enable researchers such as Pia Johansson to induce gene knockdown in target cells.
29 July 2022
Gene Therapy Development
Written Q&A
Speaker Insights – In Conversation with Pedro-Caetano Pinto
27 Jul 2022
Tissue Engineering & 3D Models
Commentary
Developing Meaningful Assays: Balancing Biological Significance and QC-Compatibility
28 Jun 2022
Cell & Gene Therapy Manufacturing

In-Depth

When to Cut and When to Inhibit
Commentary
When to Cut and When to Inhibit? A Low-Throughput, Hands-On Investigation Of CRISPR-Cut and CRISPRi Efficiencies In iPSC And Neural Cells
Gene knockdown – the manual reduction of a particular gene's expression in target cells – entails the modification of cellular development in young cells. CRISPR gene editing techniques enable researchers such as Pia Johansson to induce gene knockdown in target cells.
29 July 2022
Meaningful Assays and Cell Analytics
Commentary
Developing Meaningful Assays: Balancing Biological Significance and QC-Compatibility
Katrina Adlerz, Scientist at The University of Texas MD Anderson Cancer Center presents on developing meaningful biologic assays at the Cell Therapy Analytics Symposium 2022.
28 June 2022
Gene Manufacturing
Discussion Group Report
Gene Therapy Manufacturing
June’s Discussion Group welcomed a panel of industry experts to debate manufacturing and standardisation challenges for the commercialisation of cell and gene therapies.
21 June 2022
Anaytics Technology
Insight Article
Refining Analytics for Gene Delivery Systems
Key opinion leaders from Roche and Purespring Therapeutics debate future strategies for advancing cell and gene therapeutics.
15 June 2022
> See All

[sponsor section - bespoke content]

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Cell

> Register